AlphaYou
Overview
Smart money at a glance
Filings to Sep 30, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 1 cutEven
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $678.68
- 52-wk high
- $709.97
- High
- $684.62
- 52-wk low
- $502.84
- Low
- $672.45
- Prev close
- $681.94
- Mkt cap
- $10.58B
- P/E
- 15.6x
- Volume
- 339.5K
- Fwd P/E
- 35.2x
- Beta
- 1.19
- Div yield
- 0.18%
- P/S
- 1.6x
- P/B
- 4.8x
- Profit margin
- +10.3%
- Op margin
- +5.7%
- ROE
- +33.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DDS filings
Are insiders buying or selling Dillard's, Inc. (DDS) stock?
Neither. Dillard's, Inc. (DDS) insiders filed no open-market purchases or sales in the 90 days to Sep 30, 2026, according to SEC Form 4 filings.
Which members of Congress have traded DDS recently?
None. No member of Congress disclosed a DDS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DDS smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- DS
D.E. Shaw
$28.2M
added
- JC
JPMorgan Chase
$11.3M
added
Sells/Trims (1)
- CI
Citadel
$17.3M
trimmed
What insiders are doing
Sells (1)
- WJ
Watts J C Jr
$244K
sold
How top traders are positioned
No tracked top-trader positions in DDS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 54.7% above what analysts expected.
Earnings per share
$4.04 expected
Reports Nov 12, 2026, in 43 days
Estimates as of Sep 29, 2026
EPS expected
$8.05 to $8.05
Revenue expected
3 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 10.3%
- P/E
- 15.63
- Forward P/E
- 35.21
- Market cap
- $10.6B
Valuation
- P/S1.60
- P/B4.75
- Dividend yield0.2%
Quality
- Operating margin5.7%
- ROE33.8%
- ROA11.4%
Growth
- Beta1.19
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace